RE(ACT) Congress & IRDiRC Conference

Join gene therapy expert Nathalie Cartier-Lacave for the Advanced Therapies panel at the RE(ACT) Congress & IRDiRC Conference, which will be held as a virtual meeting from January 13-15, 2021.


Thursday, January 14, 2020
Session E, 15:30 to 17:00
Advanced therapies: gene editing, cell therapy”

  • Joseph Scheeren, USA Challenges and considerations in the regulation of gene and cell therapies”
  • Alessandro Aiuti, IT “Hematopoietic stem cell gene therapy for monogenic diseases: from experimental studies to approved drugs”
  • Hans-Dieter Volk, DE “Immunological challenges in gene and cell therapy”
  • Nathalie Cartier-Lacave, FR “Gene therapy for Huntington’s disease and spinocerebellar ataxias: from preclinical proofs of concept to first Phase 1 clinical trial”

Panel discussion: All speakers and patient representative (Oxana Illiach – CORD)